Howland Capital Management LLC Has $579,000 Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Howland Capital Management LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,144 shares of the healthcare conglomerate’s stock after buying an additional 123 shares during the quarter. Howland Capital Management LLC’s holdings in UnitedHealth Group were worth $579,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the stock. Kathleen S. Wright Associates Inc. acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth approximately $27,000. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at about $30,000. RPg Family Wealth Advisory LLC acquired a new position in UnitedHealth Group during the 3rd quarter worth approximately $37,000. Friedenthal Financial bought a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $51,000. Finally, Highline Wealth Partners LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at $55,000. 87.86% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the stock. TD Cowen boosted their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Piper Sandler cut their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Stephens raised their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Finally, Barclays dropped their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Stock Down 0.6 %

UnitedHealth Group stock opened at $526.68 on Monday. The firm has a market capitalization of $484.69 billion, a price-to-earnings ratio of 33.98, a P/E/G ratio of 1.45 and a beta of 0.61. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a 50 day simple moving average of $529.18 and a 200 day simple moving average of $564.37.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the business posted $5.83 earnings per share. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.33% of the stock is currently owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.